Good Messaging Isn’t Enough

In pharma and biotech, good messaging isn’t the same as messaging that changes behavior. A message or concept can test well in research, feel aligned to strategy, and still fail to shift real-world decisions, all because the real barriers to adoption often sit beneath what HCPs and patients can easily articulate. The result is a familiar cycle: multiple rounds of refinement, stakeholder debate, and uncertainty about what will actually drive action in the market.

Lumanity’s Behavior Change Optimizer (BCO) is designed to break that cycle by bringing behavioral science rigor and speed into campaign and message development. It’s an expert-led, AI-powered approach that helps commercial teams understand which concepts and messages are most likely to drive behavior change, which won’t, and what to do about it.